Brr Op Co, LLC Cerus Corp Transaction History

Brr Op Co, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 31, 2020	SELL	$3.84 - $4.86 $136,753 - $173,079	-35,613 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$4.51 - $6.6 $67,199 - $98,340	14,900 Added 71.94%	35,613 $200,000
Q1 2019 Apr 26, 2019	BUY	$5.16 - $6.85 $15,480 - $20,550	3,000 Added 16.94%	20,713 $129,000
Q4 2018 Feb 14, 2019	BUY	$4.89 - $7.16 $86,616 - $126,825	17,713 New	17,713 $90,000
Q2 2018 Aug 14, 2018	SELL	$5.19 - $7.25 $98,454 - $137,532	-18,970 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$3.56 - $5.74 $22,428 - $36,162	6,300 Added 49.72%	18,970 $103,000
Q4 2017 Feb 13, 2018	SELL	$2.76 - $3.95 $106,259 - $152,075	-38,500 Reduced 75.24%	12,670 $43,000
Q3 2017 Nov 09, 2017	BUY	$2.22 - $2.73 $27,750 - $34,125	12,500 Added 32.32%	51,170 $139,000
Q2 2017 Aug 09, 2017	BUY	N/A	38,670	38,670 $97,000

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $305M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Brr Op Co, LLC, based on Form 13F filings with the SEC.

Stay updated on Brr Op Co, LLC with notifications on news.